These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31903895)

  • 1. [Antibody therapeutics: an American view of an amazing present and future].
    Reichert JM
    Med Sci (Paris); 2019 Dec; 35(12):924-925. PubMed ID: 31903895
    [No Abstract]   [Full Text] [Related]  

  • 2. [A word from the coordinators].
    Pèlegrin A; Beck A; Watier H
    Med Sci (Paris); 2019 Dec; 35(12):923. PubMed ID: 31903894
    [No Abstract]   [Full Text] [Related]  

  • 3. James P. Allison Receives the 2015 Lasker-Debakey Award in Clinical Medical Research.
    Miller LJ
    Cancer Immunol Res; 2015 Nov; 3(11):1193-4. PubMed ID: 26541879
    [No Abstract]   [Full Text] [Related]  

  • 4. [Monoclonals antibodies: a recent and major therapeutic advance].
    Paintaud G; Lejarre F; Ternant D; Goupille P; Watier H
    Therapie; 2009; 64(1):1-7. PubMed ID: 19463247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic antibodies in hemostasis. From the past to the future].
    Gruel Y; Kizlik-Masson C; Lenting P
    Med Sci (Paris); 2019 Dec; 35(12):1022-1025. PubMed ID: 31903912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maintaining 'standards' for biosimilar monoclonal antibodies.
    Prior S; Metcalfe C; Hufton SE; Wadhwa M; Schneider CK; Burns C
    Nat Biotechnol; 2021 Mar; 39(3):276-280. PubMed ID: 33664522
    [No Abstract]   [Full Text] [Related]  

  • 7. Historical development of monoclonal antibody therapeutics.
    Nissim A; Chernajovsky Y
    Handb Exp Pharmacol; 2008; (181):3-18. PubMed ID: 18071939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy: past, present and future.
    Waldmann TA
    Nat Med; 2003 Mar; 9(3):269-77. PubMed ID: 12612576
    [No Abstract]   [Full Text] [Related]  

  • 9. Cancer immunotherapeutics: evolution of monoclonal antibodies to peptide immunogens.
    Murali R; Kieber-Emmons T
    Monoclon Antib Immunodiagn Immunother; 2014 Jun; 33(3):179-82. PubMed ID: 24892996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stakeholders discuss biosimilar naming, substitution.
    Traynor K
    Am J Health Syst Pharm; 2014 Mar; 71(6):446-7. PubMed ID: 24589534
    [No Abstract]   [Full Text] [Related]  

  • 11. Herceptin.
    Shepard HM; Jin P; Slamon DJ; Pirot Z; Maneval DC
    Handb Exp Pharmacol; 2008; (181):183-219. PubMed ID: 18071947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tildrakizumab-asmn: What's in a Name?
    Yang EJ; Beck KM; Liao W
    Am J Clin Dermatol; 2018 Jun; 19(3):291-292. PubMed ID: 29687361
    [No Abstract]   [Full Text] [Related]  

  • 13. 25 years of HIV-1 research - progress and perspectives.
    Wainberg MA; Jeang KT
    BMC Med; 2008 Oct; 6():31. PubMed ID: 18976462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biosimilar and interchangable biologic medications.
    Simonson W
    Geriatr Nurs; 2016; 37(5):393-394. PubMed ID: 27637457
    [No Abstract]   [Full Text] [Related]  

  • 15. Profile of Ronald Levy. Interview by Phillip Downey.
    Levy R
    Proc Natl Acad Sci U S A; 2010 Jul; 107(29):12745-6. PubMed ID: 20624971
    [No Abstract]   [Full Text] [Related]  

  • 16. Launching biosimilar rituximab: an industry opinion on biosimilar uptake in Europe.
    Trollope R; Johnson S; Ireland H
    Immunotherapy; 2017 Jun; 9(7):527-529. PubMed ID: 28523951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Patentability of an antibody: evolution of rules and practices and prospects].
    Collin M; Davison S
    Med Sci (Paris); 2019 Dec; 35(12):1175-1181. PubMed ID: 31903934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent developments in humanized MAbs for immunotherapy: a personal tribute to Dr. Martin Lockwood.
    Hale G
    Transfus Sci; 1999 Dec; 21(3):181-4. PubMed ID: 10848438
    [No Abstract]   [Full Text] [Related]  

  • 19. The NIH Clinical Center and the future of clinical research.
    Gallin JI
    Nat Med; 2011 Oct; 17(10):1221-3. PubMed ID: 21989014
    [No Abstract]   [Full Text] [Related]  

  • 20. Monoclonal antibody: the corner stone of modern biotherapeutics.
    Xia ZN; Cai XT; Cao P
    Yao Xue Xue Bao; 2012 Oct; 47(10):1275-80. PubMed ID: 23289138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.